UCSF researchers report a new spatial repellent that provides up to one year of protection against malaria and other mosquito-borne diseases, marking the first WHO-endorsed vector control tool in over four decades.
As Emergency Departments face increasing pressure, more patients are being redirected for minor injuries. While this eases the burden, missed fractures are on the rise, causing the NHS to lose millions in misdiagnosis costs.
Researchers have unveiled a pioneering method that could revolutionise the early detection of pancreatic cancer, a disease known for its late diagnosis and low survival rates.
A new study led by researchers at University College London (UCL) suggests that routine blood tests could significantly enhance early cancer diagnosis for individuals experiencing stomach pain or bloating.
Among the excitement of summer, it’s crucial to stay informed about how the season can affect our health, particularly when it comes to medications and medical devices.
Researchers from UCL and Moorfields Eye Hospital have identified potential markers in the blood that could change the treatment of glaucoma, a leading cause of irreversible blindness worldwide.
New research highlights a crucial consideration for men battling prostate cancer, a potentially heightened risk of heart disease when certain medications are combined.
Associate Professor Ailsa McGregor from the University of Otago's School of Pharmacy has set on a mission to enhance the efficacy and safety of lithium treatment for patients battling bipolar disorder (BD).
A recent multicenter randomised clinical trial has cast doubt on the efficacy of vaginal micronised progesterone (VMP) in preventing preterm birth in women with arrested preterm labour (APTL).
Researchers at the University of Notre Dame have a development in cancer therapy: a miniature, wireless LED device that can be implanted directly into deep-seated tumours.
The NHS Business Services Authority (NHSBSA) has disclosed its annual report detailing the prescription trends for mental health medications in England, covering the financial...
In a new effort to revolutionise treatment for eye injuries and disorders, a team of researchers from the University of Liverpool have secured £2.1 million in funding.
A recent advisory panel to the Food and Drug Administration (FDA) has cast significant doubt on the potential approval of MDMA-assisted therapy for post-traumatic stress disorder (PTSD).
